Evidence map›Paper›PMID 31012583›Full record

ReviewJournal of medicinal chemistry2019

Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na

John V Mulcahy, Hassan Pajouhesh, Jacob T Beckley, Anton Delwig, J Du Bois, John C Hunter

Abstract readReview
In one paragraph

Review in Journal of medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Ligand-based pharmacophore modeling for the discovery of NaJournal of computer-aided molecular design · 2026
    Article
  5. Article
  6. Review
  7. Targeting NaInternational journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. The Chemistry and Biology of the Tetrodotoxin Natural Product Family.Angewandte Chemie (International ed. in English) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Anxiety and dysautonomia symptoms in patients with a NaClinical autonomic research : official journal of the Clinical Autonomic Research Society · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John V MulcahySiteOne Therapeutics , 280 Utah Avenue, Suite 250 , South San Francisco , California 94080 , United States.ORCID 0000-0002-3997-6073
Hassan PajouheshSiteOne Therapeutics , 280 Utah Avenue, Suite 250 , South San Francisco , California 94080 , United States.
Jacob T BeckleySiteOne Therapeutics , 351 Evergreen Drive, Suite B1 , Bozeman , Montana 59715 , United States.
Anton DelwigSiteOne Therapeutics , 280 Utah Avenue, Suite 250 , South San Francisco , California 94080 , United States.
J Du BoisLokey Chemistry and Biology , Stanford University , 337 Campus Drive , Stanford , California 94305 , United States.ORCID 0000-0001-7847-1548
John C HunterSiteOne Therapeutics , 280 Utah Avenue, Suite 250 , South San Francisco , California 94080 , United States.

Funding

Development of Selective Inhibitors of NaV1.7 as Therapeutics for PainR44NS081887 · NINDS · SITEONE THERAPEUTICS, INC. · PI DELWIG, ANTON, MULCAHY, JOHN VINCENT · 2014 to 2017
$2.9M
Design, Synthesis and Evaluation of Novel Isoform-Selective Sodium Channel InhibiR43NS081887 · NINDS · SITEONE THERAPEUTICS, INC. · PI MILJANICH, GEORGE, MULCAHY, JOHN VINCENT · 2013 to 2013
$236k
NINDS NIH HHS R43 NS081887NINDS NIH HHS R44 NS081887
6 · The paper itself

Abstract

Voltage-gated sodium ion channel subtype 1.7 (Na

Indexed as

AnalgesicsAnimalsDisease Models, AnimalHumansNAV1.7 Voltage-Gated Sodium ChannelPainProtein IsoformsSignal TransductionSodium Channel BlockersSulfonamidesAnalgesicsNAV1.7 Voltage-Gated Sodium ChannelProtein IsoformsSodium Channel BlockersSulfonamides

Identifiers

PMID31012583
PMCPMC6786914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.